T V Abakumova, D R Dolgova, I I Antoneeva, T P Gening, I R Myagdieva, Yu S Slesareva
{"title":"Expression of Wnt/β-Catenin Pathway Markers in Ascites Tumor Cells in Ovarian Cancer.","authors":"T V Abakumova, D R Dolgova, I I Antoneeva, T P Gening, I R Myagdieva, Yu S Slesareva","doi":"10.1007/s10517-025-06438-3","DOIUrl":null,"url":null,"abstract":"<p><p>The expression of Wnt/β-catenin signaling markers (CTNNB1, LEF1/TCF7, c-myc, cyclinD) was assessed in ascites tumor cells with epithelial (EpCam-CK18-E-cadherin), epithelial-mesenchymal (EpCam-CK18-Vimentin), and epithelial-mesenchymal phenotype with stemness features (EpCam-CK18-Vimentin-CD44-CD133) in patients with advanced ovarian cancer. The expression of CTNNB1, LEF1/TCF7, and cyclinD was significantly increased in cells of the epithelial-mesenchymal phenotype with stemness features in patients with refractory tumor. The duration of the relapse-free period is associated with the level of CTNNB1 expression in cells of the epithelial-mesenchymal phenotype with stemness features and the level of LEF1 expression in cells of the epithelial-mesenchymal phenotype.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"69-73"},"PeriodicalIF":0.6000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06438-3","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
The expression of Wnt/β-catenin signaling markers (CTNNB1, LEF1/TCF7, c-myc, cyclinD) was assessed in ascites tumor cells with epithelial (EpCam-CK18-E-cadherin), epithelial-mesenchymal (EpCam-CK18-Vimentin), and epithelial-mesenchymal phenotype with stemness features (EpCam-CK18-Vimentin-CD44-CD133) in patients with advanced ovarian cancer. The expression of CTNNB1, LEF1/TCF7, and cyclinD was significantly increased in cells of the epithelial-mesenchymal phenotype with stemness features in patients with refractory tumor. The duration of the relapse-free period is associated with the level of CTNNB1 expression in cells of the epithelial-mesenchymal phenotype with stemness features and the level of LEF1 expression in cells of the epithelial-mesenchymal phenotype.
期刊介绍：
Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005.
World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells.
The Russian Volume Year is published in English from April.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
